Diberyllocene, a stable compound of Be(I) with a Be–Be bond
Science · 16.06.2023 · 380 (6650) · 1147-1149
DOI: 10.1126/science.adh4419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 16.06.2023. Verfasst von Josef T Boronski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Research Laboratory, Department of Chemistry, Oxford, OX1 3TA, UK. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
The complex diberyllocene, CpBeBeCp (Cp, cyclopentadienyl anion), has been the subject of numerous chemical investigations over the past five decades yet has eluded experimental characterization. We report the preparation and isolation of the compound by the reduction of beryllocene (BeCp 2 ) with a dimeric magnesium(I) complex and determination of its structure in the solid state by means of x-ray crystallography. Diberyllocene acts as a reductant in reactions that form beryllium-aluminum and beryllium-zinc bonds. Quantum chemical calculations indicate parallels between the electronic structure of diberyllocene and the simple homodiatomic species diberyllium (Be 2 ).
Autor:innen und Institutionen
- Chemistry Research Laboratory, Department of Chemistry, Oxford, OX1 3TA, UK.
ORCID-Profile: Josef T Boronski, Lewis L Wales, Simon Aldridge
Zitieren
APA
Boronski, J. T., Crumpton, A. E., Wales, L. L., & Aldridge, S. (2023). Diberyllocene, a stable compound of Be(I) with a Be–Be bond. Science, 380(6650), 1147-1149. https://doi.org/10.1126/science.adh4419
Vancouver
Boronski JT, Crumpton AE, Wales LL, Aldridge S. Diberyllocene, a stable compound of Be(I) with a Be–Be bond. Science. 2023;380(6650):1147-1149. doi:10.1126/science.adh4419
BibTeX
@article{Boronski2023,
author = {Boronski, Josef T and Crumpton, Agamemnon E and Wales, Lewis L and Aldridge, Simon},
title = {Diberyllocene, a stable compound of Be(I) with a Be–Be bond},
journal = {Science},
year = {2023},
volume = {380},
number = {6650},
pages = {1147--1149},
doi = {10.1126/science.adh4419}
}
EUVIMED